128 related articles for article (PubMed ID: 3542947)
1. Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin.
Diver JM; Wise R
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():31-41. PubMed ID: 3542947
[TBL] [Abstract][Full Text] [Related]
2. Postantibiotic effect of ciprofloxacin compared with that of five other quinolones.
Minguez F; Ramos C; Barrientos S; Loscos A; Prieto J
Chemotherapy; 1991; 37(6):420-5. PubMed ID: 1760941
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions.
Cooper MA; Andrews JM; Wise R
J Antimicrob Chemother; 1991 Sep; 28(3):399-405. PubMed ID: 1660046
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
Zhao X; Quinn B; Kerns R; Drlica K
J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
[TBL] [Abstract][Full Text] [Related]
5. Influence of subinhibitory concentrations of ceftazidime, ciprofloxacin and azithromycin on the morphology and adherence of P-fimbriated escherichia coli.
Vranes J; Zagar Z; Kurbel S
J Chemother; 1996 Aug; 8(4):254-60. PubMed ID: 8873829
[TBL] [Abstract][Full Text] [Related]
6. Bacteriostatic versus bactericidal activity of ciprofloxacin in Escherichia coli assessed by flow cytometry using a novel far-red dye.
Silva F; Lourenço O; Queiroz JA; Domingues FC
J Antibiot (Tokyo); 2011 Apr; 64(4):321-5. PubMed ID: 21326251
[TBL] [Abstract][Full Text] [Related]
7. Bactericidal activity of ciprofloxacin upon Escherichia coli and Acinetobacter baumanni.
Zemelman R; Vejar C; Bello H; Domínguez M; González G
Rev Latinoam Microbiol; 1992; 34(4):245-8. PubMed ID: 1345113
[TBL] [Abstract][Full Text] [Related]
8. Greater ciprofloxacin tolerance as a possible selectable phenotype underlying the pandemic spread of the H30 subclone of Escherichia coli sequence type 131.
Johnson JR; Porter SB; Thuras P; Johnson TJ; Price LB; Tchesnokova V; Sokurenko EV
Antimicrob Agents Chemother; 2015 Nov; 59(11):7132-5. PubMed ID: 26324269
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of zidovudine alone and in combination with ciprofloxacin against Salmonella and Escherichia coli.
Mascellino MT; Iona E; Iegri F; De Gregoris P; Farinelli S
FEMS Immunol Med Microbiol; 1993 Jun; 7(1):23-8. PubMed ID: 8364519
[TBL] [Abstract][Full Text] [Related]
10. Effects of temperature on the bactericidal activities of ciprofloxacin and levofloxacin against Escherichia coli and Pseudomonas aeruginosa.
Parte AC; Smith JT
Microbios; 1994; 80(322):31-9. PubMed ID: 7854197
[TBL] [Abstract][Full Text] [Related]
11. The response of Escherichia coli to ciprofloxacin and norfloxacin.
Elliott TS; Shelton A; Greenwood D
J Med Microbiol; 1987 Feb; 23(1):83-8. PubMed ID: 3546699
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of filamentation of Escherichia coli induced by different sub-MICs of ceftibuten at different times.
Braga PC; Piatti G
Chemotherapy; 1993; 39(4):272-7. PubMed ID: 8325129
[TBL] [Abstract][Full Text] [Related]
13. Effect of subinhibitory concentrations of ceftazidime, ciprofloxacin, and azithromycin on the hemagglutination and adherence of uropathogenic Escherichia coli strains.
Vranes J
Chemotherapy; 1996; 42(3):177-85. PubMed ID: 8983884
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric investigation of filamentation, membrane patency, and membrane potential in Escherichia coli following ciprofloxacin exposure.
Wickens HJ; Pinney RJ; Mason DJ; Gant VA
Antimicrob Agents Chemother; 2000 Mar; 44(3):682-7. PubMed ID: 10681338
[TBL] [Abstract][Full Text] [Related]
15. Composition of the outer membrane proteins of Escherichia coli strains in relation to serum susceptibility after exposure to subinhibitory concentrations of amikacin and ciprofloxacin.
Wojnicz D; Cisowska A
Int J Antimicrob Agents; 2009 Jun; 33(6):579-82. PubMed ID: 19232480
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of subinhibitory concentrations of ciprofloxacin and colistin on the morphology of cardiolipin domains in Escherichia coli membranes.
Kicia M; Janeczko N; Lewicka J; Hendrich AB
J Med Microbiol; 2012 Apr; 61(Pt 4):520-524. PubMed ID: 22160313
[TBL] [Abstract][Full Text] [Related]
17. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
Eraç B; Gill A; Amyes SG; Gülay Z
Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
[TBL] [Abstract][Full Text] [Related]
18. Effects of subinhibitory concentrations of amikacin and ciprofloxacin on the hydrophobicity and adherence to epithelial cells of uropathogenic Escherichia coli strains.
Wojnicz D; Jankowski S
Int J Antimicrob Agents; 2007 Jun; 29(6):700-4. PubMed ID: 17382520
[TBL] [Abstract][Full Text] [Related]
19. Effects of sub-minimum inhibitory concentrations of ciprofloxacin on enteroaggregative Escherichia coli and the role of the surface protein dispersin.
Mortensen NP; Fowlkes JD; Maggart M; Doktycz MJ; Nataro JP; Drusano G; Allison DP
Int J Antimicrob Agents; 2011 Jul; 38(1):27-34. PubMed ID: 21570813
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the in vitro bactericidal action of ciprofloxacin on cells of Escherichia coli in the logarithmic and stationary phases of growth.
Zeiler HJ
Antimicrob Agents Chemother; 1985 Oct; 28(4):524-7. PubMed ID: 2934022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
